Evidence map›Paper›PMID 32398351›Full record

ArticleBMJ open diabetes research & care2020

Association of glucose variability at the last day of hospitalization with 30-day readmission in adults with diabetes.

Elias K Spanakis, Lakshmi G Singh, Tariq Siddiqui, John D Sorkin, George Notas, Michelle F Magee, Jeffrey C Fink, Min Zhan, Guillermo E Umpierrez

2 registry-linked trialsOpen access · goldAbstract read
In one paragraph

Article in BMJ open diabetes research & care, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03508934 naactive not recruitingnot on this map

Continuous Glucose Monitoring in Insulin Treated Hospitalized Veterans With DM2 at Higher Risk for Hypoglycemia

TypeinterventionalSponsorVA Office of Research and DevelopmentRan2018 to 2026Enrolled218ConditionsDiabetes Mellitus, Type 2, HypoglycemiaArmsGTS (Continuous Glucose Monitoring), POC (Point of Care)
NCT03877068 nacompletednot on this map

Management of Inpatient Hyperglycemia by Continuous Glucose Monitoring in Insulin-treated Patients With Diabetes: Dexcom G6 Intervention Study

TypeinterventionalSponsorEmory UniversityRan2019 to 2021Enrolled185ConditionsDiabetes MellitusArmsDexcom G6 CGM - Continues Glucose Monitoring sensor system, POC BG - Point-of-Care Blood Glucose monitoring
3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 10 citations in OpenAlex.

  1. American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update.Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists · 2022
    Guideline
  2. Article
  3. Article
  4. Review
  5. Observational
  6. Review
  7. Patient Understanding of Discharge Instructions for Home Diabetes Self-Management and Risk for Hospital Readmission and Emergency Department Visits.Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists · 2021
    Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 2 countries.

Elias K SpanakisDivision of Endocrinology, Baltimore Veterans Affairs Medical Center, Baltimore, Maryland, USA ispanakis@som.umaryland.edu.ORCID 0000-0002-9352-7172
Lakshmi G SinghDivision of Endocrinology, Baltimore Veterans Affairs Medical Center, Baltimore, Maryland, USA.
Tariq SiddiquiDivision of Endocrinology, Diabetes, and Nutrition, University of Maryland School of Medicine, Baltimore, Maryland, USA.
John D SorkinBaltimore Veterans Affairs Medical Center GRECC (Geriatric Research, Education, and Clinical Center), Baltimore, Maryland, USA.
George NotasLaboratory of Experimental Endocrinology, University of Crete School of Medicine, Heraklion, Greece.
Michelle F MageeGeorgetown University School of Medicine; MedStar Diabetes, Research and Innovation Institutes, Washington, DC, USA.ORCID 0000-0002-4692-3201
Jeffrey C FinkDivision of Nephrology, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Min ZhanDepartment of Epidemiology and Public Health, University of Maryland, Baltimore, Maryland, USA.
Guillermo E UmpierrezDivision of Endocrinology, Metabolism, and Lipids, Emory University School of Medicine, Atlanta, Georgia, USA.ORCID 0000-0002-3252-5026
University of Maryland, Baltimore · USEmory University · USGeorgetown University · USGeriatric Research Education and Clinical Center · USUniversity of Crete · GRVeterans Health Administration · US

Funding

Implementing a Maternal health and PRegnancy Outcomes Vision for Everyone (IMPROVE)UL1TR002378 · NCATS · EMORY UNIVERSITY · PI Andres J Garcia, Elizabeth O. Ofili · 2017 to 2026
$92.1M
University of Maryland Claude D. Pepper Older Americans Independence Center (UM-OAIC)P30AG028747 · NIA · UNIVERSITY OF MARYLAND BALTIMORE · PI Stephen L. Seliger · 2006 to 2026
$28.9M
Research BaseP30DK072488 · NIDDK · UNIVERSITY OF MARYLAND BALTIMORE · PI MITCHELL, BRAXTON D, TAYLOR, SIMEON I. · 2005 to 2019
$17.3M
Translational Research Core - Engagement and Behavior ChangeP30DK111024 · NIDDK · EMORY UNIVERSITY · PI Mohammed Kumail Ali · 2016 to 2026
$13.4M
Diabetes to Go InpatientR34DK109503 · NIDDK · MEDSTAR HEALTH RESEARCH INSTITUTE · PI MAGEE, MICHELLE FISCHMANN · 2016 to 2017
$471k
Continuous Glucose Monitoring in Insulin Treated Hospitalized Veterans with DM2 at Higher Risk for HypoglycemiaI01CX001825 · VA · BALTIMORE VA MEDICAL CENTER · PI SPANAKIS, ILIAS · 2018 to 2023
–
CSRD VA I01 CX001825NCATS NIH HHS UL1 TR002378NIA NIH HHS P30 AG028747NIDDK NIH HHS P30 DK072488NIDDK NIH HHS P30 DK111024NIDDK NIH HHS R34 DK109503
6 · The paper itself

Abstract

objectiveTo evaluate whether increased glucose variability (GV) during the last day of inpatient stay is associated with increased risk of 30-day readmission in patients with diabetes. RESEARCH DESIGN AND

methodsA comprehensive list of clinical, pharmacy and utilization files were obtained from the Veterans Affairs (VA) Central Data Warehouse to create a nationwide cohort including 1 042 150 admissions of patients with diabetes over a 14-year study observation period. Point-of-care glucose values during the last 24 hours of hospitalization were extracted to calculate GV (measured as SD and coefficient of variation (CV)). Admissions were divided into 10 categories defined by progressively increasing SD and CV. The primary outcome was 30-day readmission rate, adjusted for multiple covariates including demographics, comorbidities and hypoglycemia.

resultsAs GV increased, there was an overall increase in the 30-day readmission rate ratio. In the fully adjusted model, admissions with CV in the 5th-10th CV categories and admissions with SD in the 4th-10th categories had a statistically significant progressive increase in 30-day readmission rates, compared with admissions in the 1st (lowest) CV and SD categories. Admissions with the greatest CV and SD values (10th category) had the highest risk for readmission (rate ratio (RR): 1.08 (95% CI 1.05 to 1.10), p<0.0001 and RR: 1.11 (95% CI 1.09 to 1.14), p<0.0001 for CV and SD, respectively).

conclusionsPatients with diabetes who exhibited higher degrees of GV on the final day of hospitalization had higher rates of 30-day readmission. TRIAL REGISTRATION NUMBER: NCT03508934, NCT03877068.

Indexed as

Diabetes MellitusHypoglycemiaAdultGlucoseHospitalizationHumansPatient ReadmissionGlucoseepidemiologyhospitalizationinpatient diabetes management

Identifiers

PMID32398351
PMCPMC7222883
OpenAlexW3025549698

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.